LEADER 04654nam 22006135 450 001 9910853990503321 005 20250807140227.0 010 $a9789819971411 010 $a9819971411 024 7 $a10.1007/978-981-99-7141-1 035 $a(MiAaPQ)EBC31221959 035 $a(Au-PeEL)EBL31221959 035 $a(DE-He213)978-981-99-7141-1 035 $a(CKB)30995668700041 035 $a(OCoLC)1427666340 035 $a(EXLCZ)9930995668700041 100 $a20240319d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aImmunotherapy Against Lung Cancer $eEmerging Opportunities and Challenges /$fedited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (393 pages) 225 1 $aMedicine Series 311 08$a9789819971404 311 08$a9819971403 327 $aChapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-? inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer. 330 $aThis book provides insight into the various immunotherapeutic approaches for the treatment of lung cancers. The chapters of the book discuss the detailed mechanisms of checkpoint inhibitors, co-stimulatory molecules, drugs working in the immunosuppressive environment, and various vaccines for lung cancer. A chapter of the book explores the recent applications of the oncolytic virus in lung cancer treatment and discusses the potential and direction of oncolytic virus-based therapeutic vaccines. The chapter also elucidates the current understanding of the role of Toll-Like Receptors (TLRs) in tumor progression, and the recent progress in utilizing TLR agonists as potential therapeutic agents in lung cancer treatment. Towards the end, the book reviews the applications of stereotactic body radiation therapy (SBRT) and immunotherapy for the treatment of lung cancer. This book provides useful information to a range of audiences including clinical researchers working in the field of lung cancer, and undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences. 410 0$aMedicine Series 606 $aCancer$xTreatment 606 $aTumors$xImmunological aspects 606 $aCancer Therapy 606 $aTumour Immunology 615 0$aCancer$xTreatment. 615 0$aTumors$xImmunological aspects. 615 14$aCancer Therapy. 615 24$aTumour Immunology. 676 $a616.994 700 $aBhatt$b Shvetank$01737193 701 $aEri$b Rajaraman Eri$01737194 701 $aGoh$b Bey-Hing$01737195 701 $aPaudel$b Keshav Raj$01737196 701 $aAndreoli Pinto$b Terezinha de Jesus$01737197 701 $aDua$b Kamal$01735369 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910853990503321 996 $aImmunotherapy Against Lung Cancer$94158393 997 $aUNINA